GUERRINI, ULIANO
GUERRINI, ULIANO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Mechanistic Insights into Lysine Cyclodeaminase Catalysis
2026 Y. Wei, U. Guerrini, I. Eberini
Structural determinants of IgG1-FcγRIIIa interaction: a comprehensive computational study
2026 D. Bianchi, S. Saporiti, W. Palinsky, O. Ben Mariem, U. Guerrini, M. Rossi, F. Centola, I. Eberini
Computational dissection of the cooperative effects of Fc glycosylation and light chain isotype on IgG1::FcγRIIIa recognition
2026 D. Bianchi, S. Saporiti, W. Palinsky, O. Ben Mariem, U. Guerrini, M. Rossi, F. Centola, I. Eberini
Structure-based modeling reveals molecular basis for CYP153A6’s novel activity toward toluene derivatives
2026 Y. Wei, S. Donzella, S. Foiadelli, F. Molinari, U. Guerrini, I. Eberini
In silico investigation of mAbs conformational changes upon antigen binding: impact of glycosylation and light chain isotype
2025 D. Bianchi, O. Ben Mariem, L. Palazzolo, U. Guerrini, F. Centola, M. Rossi, S. Saporiti, I. Eberini
Benchmarking and Consensus Ranking of Inverse Folding Models for Protein-Ligand Interface Design
2025 Y. Wei, U. Guerrini, I. Eberini
CypEGAT: A Deep Learning Framework Integrating Protein Language Model and Graph Attention Networks for Enhanced CYP450s Substrate Prediction
2025 Y. Wei, U. Guerrini, I. Eberini
Structural determinants of IgG1-FcγRIIIa interaction: A comprehensive computational study
2025 D. Bianchi, S. Saporiti, W. Palinsky, O. Ben Mariem, U. Guerrini, M. Rossi, F. Centola, I. Eberini
Structural Insights into CYP3A4–P-gp Interactions and Their Role in Personalized Autoimmune Drug Therapy
2025 Y. Wei, U. Guerrini, I. Eberini
Correlation Between CYP1A2 Genetic Polymorphism and Drug Response
2025 Y. Wei, U. Guerrini, I. Eberini
Computational Analysis and Prediction of CYP1A2-Related Toxicants for Safer Drug Discovery
2025 Y. Wei, U. Guerrini, I. Eberini
Computational Strategies for Engineering Non-Heme and Heme Iron-Dependent Enzymes
2025 Y. Wei, U. Guerrini, F. Molinari, I. Eberini
The Use of Machine Learning in Human Cytochrome P450s Substrate Prediction
2025 Y. Wei, U. Guerrini, I. Eberini
In silico description of OCTN1 recognition mechanism and the role of sodium in substrate binding
2024 O. BEN MARIEM, L. Palazzolo, U. Guerrini, T. Laurenzi, D. Bianchi, Y. Wei, I. Eberini
In silico description of OCTN1 recognition mechanism and the role of sodium in substrate binding
2024 O. Ben Mariem, L. Palazzolo, U. Guerrini, T. Laurenzi, D. Bianchi, Y. Wei, I. Eberini
Development of in silico methodologies to predict the toxicity of novel proteins in the context of food and feed risk assessment
2024 L. Palazzolo, T. Laurenzi, O. Ben Mariem, A. Bassan, U. Guerrini, I. Eberini
Investigation of in silico studies for cytochrome P450 isoforms specificity
2024 Y. Wei, L. Palazzolo, O. Ben Mariem, D. Bianchi, T. Laurenzi, U. Guerrini, I. Eberini
Comparison of Protein Design Tools For Engineering Non-heme Iron Dependent Dioxygenases
2024 Y. Wei, L. Palazzolo, T. Laurenzi, U. Guerrini, F. Molinari, I. Eberini
In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3
2024 L. Montavoci, O. Ben Mariem, S. Saporiti, T. Laurenzi, L. Palazzolo, A.F. Ossoli, U. Guerrini, L. Calabresi, I. Eberini
Atomistic description of the OCTN1 recognition mechanism via in silico methods
2024 O. Ben Mariem, L. Palazzolo, B. Torre, Y. Wei, D. Bianchi, U. Guerrini, T. Laurenzi, S. Saporiti, E. De Fabiani, L. Pochini, C. Indiveri, I. Eberini